| Members |
targetComponentId |
| Vectorcardiogram with ECG |
Electrocardiogram with vectorcardiogram |
| vekuroniumbromid 4 mg, pulver till injektionsvätska, flaska |
Product containing only vecuronium in parenteral dose form (medicinal product form) |
| Veillonella alcalescens |
Veillonella parvula |
| Veillonella alcalescens ss alcalescens |
Veillonella parvula |
| Veillonella alcalescens ss criceti |
Veillonella criceti |
| Veillonella alcalescens ss dispar |
Veillonella dispar |
| Veillonella alcalescens ss ratii |
Veillonella ratti |
| velagluceras alfa 200 enheter, frystorkat pulver till injektionsvätska |
Product containing only velaglucerase alfa (medicinal product) |
| venlafaxinhydroklorid 37,5 mg, kapsel med modifierad frisättning |
Venlafaxine only product in oral dose form |
| venlafaxinhydroklorid 37,5 mg, depåkapsel |
Venlafaxine only product in oral dose form |
| Ventral surface of tongue |
Structure of inferior surface of tongue |
| kammarseptumdefekt med åt vänster felinriktat utloppsseptum som överrider aortaklaff |
Ventricular septal defect with posterior malaligned outlet septum with overriding aortic valve (disorder) |
| kammarseptumdefekt med åt vänster felinriktat utloppsseptum som överrider pulmonalklaff |
Ventricular septal defect with posterior malaligned outlet septum with overriding pulmonary valve (disorder) |
| kammarseptumdefekt med åt höger felinriktat utloppsseptum som överrider aortaklaff |
Ventricular septal defect with anterior malaligned outlet septum with overriding aortic valve (disorder) |
| kammarseptumdefekt med åt höger felinriktat utloppsseptum som överrider pulmonalklaff |
Ventricular septal defect with anterior malaligned outlet septum with overriding pulmonary valve (disorder) |
| verapamilhydroklorid 100 mg, kapsel |
Product containing only verapamil in oral dose form (medicinal product form) |
| verapamilhydroklorid 100 mg, kapsel med modifierad frisättning |
Product containing only verapamil in oral dose form (medicinal product form) |
| verapamilhydroklorid 100 mg, depåkapsel |
Product containing only verapamil in oral dose form (medicinal product form) |
| verapamilhydroklorid 180 mg, tablett med modifierad frisättning |
Product containing only verapamil in oral dose form (medicinal product form) |
| verapamilhydroklorid 180 mg, depåtablett |
Product containing only verapamil in oral dose form (medicinal product form) |
| verapamilhydroklorid 180 mg, tablett |
Product containing only verapamil in oral dose form (medicinal product form) |
| verapamilhydroklorid 200 mg, kapsel |
Product containing only verapamil in oral dose form (medicinal product form) |
| verapamilhydroklorid 200 mg, kapsel med modifierad frisättning |
Product containing only verapamil in oral dose form (medicinal product form) |
| verapamilhydroklorid 200 mg, depåkapsel |
Product containing only verapamil in oral dose form (medicinal product form) |
| verapamilhydroklorid 300 mg, kapsel |
Product containing only verapamil in oral dose form (medicinal product form) |
| verapamilhydroklorid 300 mg, kapsel med modifierad frisättning |
Product containing only verapamil in oral dose form (medicinal product form) |
| verapamilhydroklorid 300 mg, depåkapsel |
Product containing only verapamil in oral dose form (medicinal product form) |
| verapamilhydroklorid 360 mg, kapsel |
Product containing only verapamil in oral dose form (medicinal product form) |
| verapamilhydroklorid 360 mg, kapsel med modifierad frisättning |
Product containing only verapamil in oral dose form (medicinal product form) |
| verapamilhydroklorid 360 mg, depåkapsel |
Product containing only verapamil in oral dose form (medicinal product form) |
| verapamilhydroklorid 400 mg, tablett med modifierad frisättning |
Product containing only verapamil in oral dose form (medicinal product form) |
| verapamilhydroklorid 400 mg, depåtablett |
Product containing only verapamil in oral dose form (medicinal product form) |
| muntlig rapport |
Verbal report (record artifact) |
| Vernix caseosa |
Vernix caseosa (substance) |
| Verruca plana |
Plane wart |
| Verruca vulgaris |
Verruca vulgaris |
| Vesicular stomatitis |
Vesicular stomatitis |
| vesikulär stomatit-virus, Cocal |
Cocal virus (organism) |
| Vespa |
Wasp |
| Vestibular neuronitis |
Epidemic vertigo |
| Veterinary nursing AND/OR grooming procedure |
Nursing procedure |
| vibration av livmoderhalsen |
Uterine cervix manipulation |
| Vibration of cervix |
Uterine cervix manipulation |
| Vibrio anguillarium |
Listonella anguillarum (organism) |
| Vibrio carchariae |
Vibrio harveyi |
| Vibrio costicola |
Salinivibrio costicola |
| Vibrio damsela |
Photobacterium damselae (organism) |
| Vibrio fischeri |
Aliivibrio fischeri |
| Vibrio hollisae |
Grimontia hollisae (organism) |
| Vibrio marinus |
Moritella marina (organism) |
| Vibrio trachuri |
Vibrio harveyi |
| Vibrionaceae ichthyoenteri |
Vibrio ichthyoenteri (organism) |
| trakasserar andra |
Abusive behavior towards people (finding) |
| Villous adenoma |
Villous adenoma (morphologic abnormality) |
| vinblastinsulfat 30 mg/30 ml, injektionsvätska, lösning |
Product containing only vinblastine in parenteral dose form (medicinal product form) |
| vinblastinsulfat 30 mg/30ml, för infusion |
Product containing only vinblastine in parenteral dose form (medicinal product form) |
| vinblastinsulfat 50 mg/50 ml, infusionsvätska, lösning |
Product containing only vinblastine in parenteral dose form (medicinal product form) |
| vinblastinsulfat 50 mg/50 ml, för infusion |
Product containing only vinblastine in parenteral dose form (medicinal product form) |
| Vinca alkaloid |
Vinca alkaloid |
| vinkristin 1 mg, pulver och vätska till injektionslösning, flaska |
Vincristine only product in parenteral dose form |
| vinkristin 1 mg, pulver till injektionsvätska, lösning, flaska |
Vincristine only product in parenteral dose form |
| vinkristin 2 mg, pulver och vätska till injektionslösning, flaska |
Vincristine only product in parenteral dose form |
| vinkristin 2 mg, pulver till injektionsvätska, lösning, flaska |
Vincristine only product in parenteral dose form |
| vinkristin 5 mg, pulver och vätska till injektionslösning, flaska |
Vincristine only product in parenteral dose form |
| vinkristin 5 mg, pulver till injektionsvätska, lösning, flaska |
Vincristine only product in parenteral dose form |
| vinkristinsulfat 10 mg/50 ml, infusionsvätska, lösning |
Vincristine only product in parenteral dose form |
| vinkristinsulfat 10 mg/50 ml, för infusion |
Vincristine only product in parenteral dose form |
| vinkristinsulfat 5 mg/50 ml, infusionsvätska, lösning |
Vincristine only product in parenteral dose form |
| vinkristinsulfat 5 mg/50 ml, för infusion |
Vincristine only product in parenteral dose form |
| vinorelbin 10 mg/1 ml, intravenös vätska, lösning |
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| vinorelbin 50 mg/5 ml, intravenös vätska, lösning |
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Vinorelbine tartrate 10mg/mL injection solution 1mL vial |
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Vinorelbine tartrate 10mg/mL injection solution 5mL vial |
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Vinorelbine tartrate 10mg/mL solution |
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Viper type C oncovirus |
Viper retrovirus (organism) |
| Vipera |
Subfamily Viperinae (organism) |
| Vipera persica |
Pseudocerastes persicus |
| Viral gastroenteritis due to other viral agents |
Viral gastroenteritis |
| Viral hepatitis, non-A, non-B |
Viral hepatitis C |
| virusinfektion, indelning efter lokalisation |
Viral disease |
| Visually threatening diabetic retinopathy |
Visually threatening diabetic retinopathy |
| Vitamin A deficiency with other ocular manifestations |
Vitamin A deficiency with ocular manifestation |
| allergi mot B12-vitamin |
Allergy to vitamin B12 and/or vitamin B12 derivative (finding) |
| Vitamin B>12< deficiency neuropathy |
Subacute combined degeneration of spinal cord |
| D3-vitaminmetabolit |
Vitamin D analogue |
| Vitamin P preparation |
Bioflavonoid |
| Vitropression |
Vitropression (procedure) |
| Vocal |
Vocal resonance |
| röststörning orsakad av transsexualism |
Speech and language disorder |
| Vomiting |
Vomiting (disorder) |
| Vomiting disorder |
Vomiting (disorder) |
| Vulva excision |
Vulvectomy |
| Vulvar ulceration |
Ulceration of vulva |
| Waardenburg syndrome, types I and II |
Waardenburg's syndrome |
| Wagstaffes fraktur |
Avulsion fracture of anterior fibula (disorder) |
| warfarin 2 mg/ml, pulver till injektionsvätska, lösning |
Warfarin sodium 5 mg powder for solution for injection vial |
| varm miljö |
Warm environment |
| Wart snake |
Family Acrochordidae (organism) |
| Washing |
Action |
| Washing of animal |
Bathing patient |
| vatten till injektion, påse 100 ml |
Water only product in parenteral dose form |